Bradley Beatson1, Jiangxia Wang2, Michael V Boland3, Pradeep Ramulu1, Oliver Schein1, Michael J Fliotsos1, Michael E Sulewski1, Divya Srikumaran4. 1. From the Wilmer Eye Institute, Johns Hopkins University School of Medicine (B.B., M.V.B., P.R., O.S., M.J.F., M.E.S., D.S.), Baltimore, Maryland. 2. Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health (J.W.), Baltimore, Maryland. 3. From the Wilmer Eye Institute, Johns Hopkins University School of Medicine (B.B., M.V.B., P.R., O.S., M.J.F., M.E.S., D.S.), Baltimore, Maryland; Massachusetts Eye and Ear, Harvard Medical School (M.V.B.), Boston, Massachusetts. 4. From the Wilmer Eye Institute, Johns Hopkins University School of Medicine (B.B., M.V.B., P.R., O.S., M.J.F., M.E.S., D.S.), Baltimore, Maryland. Electronic address: dsrikum1@jhmi.edu.
Abstract
PURPOSE: To assess risk factors contributing to corneal decompensation following glaucoma drainage device (GDD) implantation. DESIGN: Retrospective case control study. METHODS: Records of 1610 eyes that underwent GDD implantation between June 1, 2009, and April 1, 2020, at the Johns Hopkins Wilmer Eye Institute were reviewed. Seventy-nine eyes (5%) developed corneal decompensation, of which 46 underwent keratoplasty. These 79 cases were matched with 220 controls. Cox proportional hazard models with robust standard error estimates to account for clustering at the matched-pair level were used to assess risk factors for corneal decompensation. Kaplan-Meier survival analysis analyzed time to corneal decompensation. RESULTS: The mean (SD) age of cases and controls was 68 (12.3) and 60.5 (15.9) years, respectively. The mean time from GDD implantation to corneal decompensation was 32 months, and the cumulative probability of developing decompensation at 3, 6, and 9 years was 4.7%, 9.2%, and 14.8%, respectively. Final visual outcomes in cases were worse, with a final mean ± SD visual acuity (logMAR) of 1.96±1.25 relative to a mean±SD visual acuity of 1.11±1.36 in controls (P < .001). In the multivariable model, significant risk factors for corneal decompensation were increased age (adjusted hazard ratio [AHR] 1.39, 95% CI 1.18, 1.63; P ≤ .001), history of Fuchs dystrophy or iridocorneal endothelial syndrome (AHR 9.18, 95% CI 5.35, 15.74; P ≤ .001), and postoperative complications such as hypotony (AHR 3.25, 95% CI 1.85, 5.72; P ≤ .001) and tube-cornea touch (AHR 6.37, 95% CI 3.77, 10.75; P ≤ .001). CONCLUSIONS: The risk of postoperative corneal decompensation is persistent over time. Patients receiving GDDs, particularly those with advanced age, preexisting corneal pathology, and postoperative complications, should be counseled regarding their increased risk for corneal decompensation.
PURPOSE: To assess risk factors contributing to corneal decompensation following glaucoma drainage device (GDD) implantation. DESIGN: Retrospective case control study. METHODS: Records of 1610 eyes that underwent GDD implantation between June 1, 2009, and April 1, 2020, at the Johns Hopkins Wilmer Eye Institute were reviewed. Seventy-nine eyes (5%) developed corneal decompensation, of which 46 underwent keratoplasty. These 79 cases were matched with 220 controls. Cox proportional hazard models with robust standard error estimates to account for clustering at the matched-pair level were used to assess risk factors for corneal decompensation. Kaplan-Meier survival analysis analyzed time to corneal decompensation. RESULTS: The mean (SD) age of cases and controls was 68 (12.3) and 60.5 (15.9) years, respectively. The mean time from GDD implantation to corneal decompensation was 32 months, and the cumulative probability of developing decompensation at 3, 6, and 9 years was 4.7%, 9.2%, and 14.8%, respectively. Final visual outcomes in cases were worse, with a final mean ± SD visual acuity (logMAR) of 1.96±1.25 relative to a mean±SD visual acuity of 1.11±1.36 in controls (P < .001). In the multivariable model, significant risk factors for corneal decompensation were increased age (adjusted hazard ratio [AHR] 1.39, 95% CI 1.18, 1.63; P ≤ .001), history of Fuchs dystrophy or iridocorneal endothelial syndrome (AHR 9.18, 95% CI 5.35, 15.74; P ≤ .001), and postoperative complications such as hypotony (AHR 3.25, 95% CI 1.85, 5.72; P ≤ .001) and tube-cornea touch (AHR 6.37, 95% CI 3.77, 10.75; P ≤ .001). CONCLUSIONS: The risk of postoperative corneal decompensation is persistent over time. Patients receiving GDDs, particularly those with advanced age, preexisting corneal pathology, and postoperative complications, should be counseled regarding their increased risk for corneal decompensation.
Authors: Ben J Janson; Wallace L Alward; Young H Kwon; Daniel I Bettis; John H Fingert; Lorraine M Provencher; Kenneth M Goins; Michael D Wagoner; Mark A Greiner Journal: Surv Ophthalmol Date: 2017-11-14 Impact factor: 6.048
Authors: Karun S Arora; Alan L Robin; Kevin J Corcoran; Suzanne L Corcoran; Pradeep Y Ramulu Journal: Ophthalmology Date: 2015-06-16 Impact factor: 12.079
Authors: Donald L Budenz; William J Feuer; Keith Barton; Joyce Schiffman; Vital P Costa; David G Godfrey; Yvonne M Buys Journal: Am J Ophthalmol Date: 2015-11-18 Impact factor: 5.258
Authors: Konstantine Purtskhvanidze; Mark Saeger; Felix Treumer; Johann Roider; Bernhard Nölle Journal: BMC Ophthalmol Date: 2019-01-10 Impact factor: 2.209